基本信息
views: 49
Career Trajectory
Bio
研究方向
溶瘤病毒疗法(Oncolytic Virotherapy)是一种靶向治疗、免疫治疗和基因治疗相结合的新兴抗肿瘤疗法。本团队专注于新型溶瘤病毒的基础和应用基础研究,研究方向主要包括:
1. 溶瘤病毒靶向杀伤肿瘤的分子机制研究;
2. 免疫系统对溶瘤病毒的“双刃剑”调控机制研究;
3. 应用人工智能和合成生物学策略发展新一代溶瘤病毒。
溶瘤病毒疗法(Oncolytic Virotherapy)是一种靶向治疗、免疫治疗和基因治疗相结合的新兴抗肿瘤疗法。本团队专注于新型溶瘤病毒的基础和应用基础研究,研究方向主要包括:
1. 溶瘤病毒靶向杀伤肿瘤的分子机制研究;
2. 免疫系统对溶瘤病毒的“双刃剑”调控机制研究;
3. 应用人工智能和合成生物学策略发展新一代溶瘤病毒。
Education
Sign in to view more
Experience
Sign in to view more
Research Interests
Papers共 112 篇Patents共 42 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Luohai Chen, Dequan Yang, Yueriguli Yusufu, Haikuan Liu, Man Liu,Yuan Lin, Yanji Luo, Qiao He,Minhu Chen,Zhirong Zeng,Ning Zhang, Yu Wang
Cancersno. 2 (2025): 309
Taofang Hao, Yuanyuan Li, Qianyao Ren, Ying Zeng, Leyi Gao,Wenbo Zhu, Jiankai Liang,Yuan Lin,Jun Hu,Guangmei Yan, ShuXin Sun, Jing Cai
Molecular Therapy Oncologyno. 1 (2025): 200919
Gastroenterologyno. 5 (2024): S-1341
Case Reports in Oncology (2024)
Gastroenterologyno. 5 (2024): S-369
Jingyi Tan,Jiayu Zhang,Cheng Hu, Gongwei Wang,Qianyao Ren, Chaoqun Wang,Jia Dan, Zexin Zeng,Jun Hu,Wenbo Zhu,Jiankai Liang,Jing Cai,Ying Liu,Guangmei Yan,Yuan Lin
ACTA PHARMACEUTICA SINICA Bno. 6 (2024): 2554-2566
Luohai Chen, Xiaoxuan Lin,Man Liu,Wenli Wen,Yuan Lin,Qiao He, Yanji Luo, Yu Wang,Zhirong Zeng,Minhu Chen,Ning Zhang
Basic Gastroenterology (2024)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024)
DISCOVER ONCOLOGYno. 1 (2024)
Xiao-yu Chen,Ying Liu,Wen-bo Zhu,Shu-hao Li,Song Wei, Jing Cai,Yuan Lin,Jian-kai Liang,Guang-mei Yan, Li Guo,Cheng Hu
ISCIENCEno. 11 (2024)
Load More
Author Statistics
#Papers: 113
#Citation: 2027
H-Index: 28
G-Index: 42
Sociability: 6
Diversity: 3
Activity: 25
Loading...
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn